- Home
- RNP vs COLL Comparison
RNP vs COLL Comparison
Compare RNP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNP
- COLL
- Stock Information
- Founded
- RNP 2003
- COLL 2002
- Country
- RNP United States
- COLL United States
- Employees
- RNP N/A
- COLL N/A
- Industry
- RNP Investment Managers
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- RNP Finance
- COLL Health Care
- Exchange
- RNP Nasdaq
- COLL Nasdaq
- Market Cap
- RNP N/A
- COLL 958.8M
- IPO Year
- RNP N/A
- COLL 2015
- Fundamental
- Price
- RNP $22.99
- COLL $32.52
- Analyst Decision
- RNP
- COLL Strong Buy
- Analyst Count
- RNP 0
- COLL 4
- Target Price
- RNP N/A
- COLL $43.75
- AVG Volume (30 Days)
- RNP 117.6K
- COLL 304.4K
- Earning Date
- RNP 01-01-0001
- COLL 08-07-2025
- Dividend Yield
- RNP 7.94%
- COLL N/A
- EPS Growth
- RNP N/A
- COLL N/A
- EPS
- RNP N/A
- COLL 1.25
- Revenue
- RNP N/A
- COLL $664,283,000.00
- Revenue This Year
- RNP N/A
- COLL $20.04
- Revenue Next Year
- RNP N/A
- COLL $3.98
- P/E Ratio
- RNP N/A
- COLL $25.91
- Revenue Growth
- RNP N/A
- COLL 17.17
- 52 Week Low
- RNP $15.52
- COLL $23.23
- 52 Week High
- RNP $21.27
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- RNP 67.93
- COLL 69.85
- Support Level
- RNP $22.51
- COLL $30.60
- Resistance Level
- RNP $22.85
- COLL $33.22
- Average True Range (ATR)
- RNP 0.30
- COLL 0.85
- MACD
- RNP 0.02
- COLL 0.27
- Stochastic Oscillator
- RNP 100.00
- COLL 82.32
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.